Nkarta
IPOPioneering off-the-shelf NK cell therapy for autoimmune disease
Public · South San Francisco, United States · Founded 2015 · $126.8M raised
- Headquarters
- South San Francisco, California
- Employees
- 51–200
- Founded
- 2015
- Business Model
- B2B
- Website
- nkarta.com
- Total Funding
- $126.8M
- Last Round
- $114.0M Series BSep 2019
- Rounds
- 2
- Type
- Public
About
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies to treat autoimmune disease. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies, Nkarta is building a pipeline of NK cell therapies engineered for deep therapeutic impact. The company's lead candidate, NKX019, targets CD19-expressing B cells and is designed to be administered in outpatient settings without the manufacturing complexity or safety risks of autologous CAR-T therapies.
Summary
Nkarta is a Biotech company based in South San Francisco, United States, founded in 2015. It has raised $126.8M in total across 2 rounds, most recently a $114.0M Series B round in Sep 2019. Investors include Boxer Capital, Samsara BioCapital and Amgen.
Tech & App Stack
6 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Mar 2024
Sign up to see all 4 rounds
Series A through Secondary Market — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/nkarta"><img src="https://indexed.vc/api/badge/company/nkarta" alt="Nkarta on Indexed.vc" width="260" height="76" /></a>